Home/Investors/Management

Management

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

5

Top Stage

Phase 2

Investment Focus

Major Depressive Disorder Treatment-Resistant Depression Spinal Cord Injury Traumatic Brain Injury Oncology

Portfolio Companies

Company	Stage	Valuation	Focus
Mapreg	Phase 2	—	Major Depressive Disorder, Treatment-Resistant Depression
OncoAssure	Commercial	—	Oncology

Frequent Co-Investors

Institutional investors1 shared Founders1 shared Private Investors1 shared Business Angels/Family Offices1 shared GENERALI FR (main shareholder)1 shared Angel investment groups1 shared